tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dennis Ding, 11 are a BUY (73.33%), 4 are a HOLD (26.67%).
Analyst Dennis Ding, currently employed at JEFFERIES, carries an average stock price target met ratio of 53.57% that have a potential upside of 19.63% achieved within 174 days.
Dennis Ding’s has documented 30 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ROIV, Roivant Sciences Ltd at 18-Sep-2025.
Analyst best performing recommendations are on NGM (NGM BIOPHARMACEUTICALS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$5
$0.62 (14.16%)
$5
1 months 29 days ago
(10-Aug-2025)
4/13 (30.77%)
$1.65 (49.25%)
136
Buy
$5
$0.62 (14.16%)
$5
8 months 19 days ago
(20-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy
$5
$0.62 (14.16%)
$4
1 years 2 months 8 days ago
(01-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
$5
$0.62 (14.16%)
3 years 8 months 8 days ago
(01-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
$7
4 years 3 months 12 days ago
(27-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Dennis Ding is most bullish on?
What Year was the first public recommendation made by Dennis Ding?
